Immunovaccine decreases 1.7% November 06, 2018 17:00 EST
CANADIAN DAILY STOCK REPORT
Immunovaccine Inc. (TSX:IMV), Canada's 8th largest Biotechnology company by market cap, has decreased 13.0c (1.7%) from its last trading session of November 05 to close at CAD7.30. Compared with the S&P/TSX 60 Index which rose 4.7 points (0.5%) in the day, the relative price change was -2.3%. The volume was 0.5 times the average daily trading volume of 41,094 shares. Its MCap is CAD328.4 million (US$250.5 million).
Highlights in today's Report: